29.01.2020 • News

Catalent Appoints Ricci Whitlow as President of Clinical Supply Services

Catalent has appointed Ricci Whitlow as president of its Clinical Supply...
Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. Source: Catalent

Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. She succeeds Paul Hegwood, who will retire in March 2020.

Whitlow has over 25 years’ experience in the pharmaceutical biologics and medical device industry, and she rejoins Catalent after two-and-a-half years, having previously held the position of vice president Operations. In her most recent position, she served as senior vice president of Technical and Corporate Operations at OptiNose.

During her career, she has also worked for LifeCell and Johnson & Johnson. Whitlow holds a master’s degree in business administration from the TRIUM program of NYU Stern School of Business, London School of Economics and HEC Paris; as well as a B.Sc. in Industrial Engineering from Texas A&M University.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.